Clearstead Advisors’s abrdn Healthcare Investors HQH Stock Holding History

Clearstead Advisors’s Portfolio HQH Stock Details HQH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.4K	Buy	+1,215	New	+$27K	﹤0.01%	1667

Other funds holding HQH

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Samalin Investment Counsel Chappaqua, New York $319M AUM 12.97% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Smith Asset Management Chiefland, Florida $123M AUM 1.3% 1-Year Est. Return

NWF Advisory Services Los Angeles, California $1.07B AUM 35.62% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

SCM

Sage Capital Management Stockton, New Jersey $263M AUM 22.29% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Atomi Financial Group New York $3.91B AUM 21.86% 1-Year Est. Return

Clearstead Advisors's HQH Position: Q3 2026 in Review

Clearstead Advisors opened a new position in abrdn Healthcare Investors (HQH) in Q3 2026: 1,215 shares worth $25.4K. The stake represents ﹤0.01% of the portfolio and ranks #1667 among its holdings.

63 funds tracked by Wall St. Rank hold HQH as of Q3 2026.

Clearstead Advisors held 1,215 shares of abrdn Healthcare Investors worth $25.4K as of Q3 2026.
abrdn Healthcare Investors was a new Clearstead Advisors position in Q3 2026.
abrdn Healthcare Investors made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #1667 holding.
63 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2026.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.